Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2026-05-19 16:15:07 ET · period of report 2026-05-18 · accession 0001593087-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-19 16:15 | 2026-05-18 | CAPR | Bergmann Anthony | CFO | M - OptEx | $1.39 | +3,000 | 11.2K | +36% | +$4,170 |
| D | 2026-05-19 16:15 | 2026-05-18 | CAPR | Bergmann Anthony | CFO | M - OptEx | $0.00 | -3,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | M | A | 3,000 | $1.39 | 11,223 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-18 | M | D | 3,000 | $0.00 | 0 | D | $1.39 · — to 2026-06-02 | 3,000 Common Stock | (F1) This option was granted on June 2, 2016 and was previously reported as covering 30,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. (F2) Shares vested 1/48th on the first day of each month commencing as of July 1, 2016. (F1) This option was granted on June 2, 2016 and was previously reported as covering 30,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. |